ACLX vs GILD: Which Stock is Better?

Side-by-side comparison of Arcellx Inc and Gilead Sciences Inc in 2026

Comparison Updated:

ACLX

Arcellx Inc

$72.17

GILD

Gilead Sciences Inc

$124.14

Key Metrics Comparison

MetricACLXGILDWinner
Market Cap$4.17B$154.03BGILD
P/E RatioN/A19.22GILD
EPS (TTM)$N/A$6.46GILD
Revenue Growth-0.8%0.0%GILD
Gross Margin-368.5%78.7%GILD

Analyze ACLX

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACLX or GILD a better investment?

Comparing ACLX and GILD: Arcellx Inc has a market cap of $4.17B while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACLX and GILD?

ACLX (Arcellx Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACLX or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ACLX or GILD?

GILD has higher revenue growth at 0.0% vs -0.8% for ACLX.

Which company is more profitable: ACLX or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to -368.5% for ACLX.

Which is the larger company: ACLX or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $4.17B for ACLX.

Should I buy ACLX or GILD in 2026?

Both ACLX and GILD have investment merit. ACLX trades at $72.17 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACLX and GILD stock?

Key differences: Market Cap ($4.17B vs $154.03B), P/E Ratio (N/A vs 19.2x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (-368.5% vs 78.7%).

Popular Stock Comparisons